Margoum Souad, Berhili Soufiane, Bouabid Meriem, Moukhlissi Mohamed, Loubna Mezouar
Radiation Oncology, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.
Cureus. 2024 May 16;16(5):e60430. doi: 10.7759/cureus.60430. eCollection 2024 May.
Secretory breast carcinoma (SBC) is an extremely rare entity of breast cancer, which can affect all age groups. The diagnosis is based on the characteristic microscopic appearance, and despite the triple negativity or low hormone receptor positivity, SBC is generally characterized by a favorable prognosis. Due to the rarity of the disease, no clear consensus on optimal treatment is available. Nevertheless, conservative surgery or mastectomy is the main therapeutic option. The efficacy of chemotherapy, radiotherapy, and hormone therapy in this pathology has not been rigorously explored. We report the case of a 65-year-old woman with SBC treated with surgery and adjuvant radiotherapy, with a review of the literature.
分泌性乳腺癌(SBC)是一种极其罕见的乳腺癌类型,可发生于所有年龄组。诊断基于其特征性的显微镜表现,尽管SBC具有三阴性或低激素受体阳性的特点,但其总体预后通常较好。由于该疾病罕见,目前对于最佳治疗方案尚无明确共识。尽管如此,保乳手术或乳房切除术仍是主要的治疗选择。化疗、放疗和激素治疗在这种病理类型中的疗效尚未得到严格探究。我们报告了一例65岁分泌性乳腺癌女性患者接受手术及辅助放疗的病例,并对相关文献进行了综述。